Home
>
US Stocks
>
Immatics N.V
Immatics N.V
IMTX

Immatics N.V

$13.7712.22%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
14.15
Today Low/High
13.44 / 14.15
52 Week Low/High
$8.66 / $18.42
Market Cap
$763.71M

Company Details

Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer.
Organisation
Immatics N.V
Headquaters
Tuebingen, Baden Wuerttemberg, Germany
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Immatics N.V share price today

Can Indians buy Immatics N.V shares?

How can I buy Immatics N.V shares from India?

Can Fractional shares of Immatics N.V be purchased?

What are the documents required to start investing in Immatics N.V stocks?

We are a SEBI registered investement advisor